Latest news and upcoming events

05 May 2021

Cytoki Pharma raises $45 million Series A financing

Upcoming events
  • Bioequity 2021
    17 May – 19 May 2021,

  • Biospain 2021
    29 September – 1 October 2021,
    Pamplona, Spain

Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board

Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board.

VarmX appoints Dr. Gerard Short as Chief Medical Officer

VarmX today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO).

Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)

Minoryx Therapeutics today announces that a lead investigator of the Minoryx Phase 2/3 ADVANCE clinical trial will present further results of the study at the 2021 Virtual Annual Meeting of the American Neurological Association.

Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer

IInbiomotion SL today announced that Alta Life Sciences has led a significantly oversubscribed investment round in the company.

Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors

Splice Bio announced today that it has appointed Jean-Philippe Combal as Chairman of its Board of Directors.

Hospital Vall d’Hebron Investigators Publish Early Data on Anaconda Biomed’s Mechanical Thrombectomy System for Ischemic Stroke

Initial single-center clinical study data supporting Anaconda Biomed’s Advanced Neurovascular Access™ (ANA) Catheter System for the treatment of ischemic stroke have been published

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

AM-Pharma B.V. today announced that the first patients with COVID-19 infection and sepsis-associated acute kidney injury (SA-AKI) have been enrolled in the Company’s Phase III REVIVAL pivotal trial

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients.

Aura Biosciences Appoints David Johnson to Its Board of Directors

Aura Biosciences today announced the appointment of David Johnson to its Board of Directors.

International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer

ONA Therapeutics, Absolute Antibody and RIC – three leading European companies in the biotech landscape – have been awarded a Eurostars grant for a two-year project


Subscribe to our weekly newsletter for the latest
updates on life sciences investments.